Cullinan Associates Inc Danaher Corp Transaction History

Cullinan Associates Inc

  • $1.5 Billion
  • Q2 2025

A detailed history of Cullinan Associates Inc transactions in Danaher Corp stock. As of the latest transaction made, Cullinan Associates Inc holds 1,200 shares of DHR stock, worth $257,988. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,200
Previous 1,300 7.69%
Holding current value
$257,988
Previous $266,000 10.9%
% of portfolio
0.02%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 22, 2025
SELL
$174.64 - $205.16 $17,464 - $20,516
-100 Reduced 7.69%
1,200 $237,000
Q3 2024

Oct 23, 2024
SELL
$239.25 - $280.76 $119,625 - $140,380
-500 Reduced 27.78%
1,300 $361,000
Q1 2024

Apr 18, 2024
SELL
$224.58 - $256.19 $134,748 - $153,714
-600 Reduced 25.0%
1,800 $449,000
Q2 2023

Jul 14, 2023
BUY
$224.99 - $256.14 $134,994 - $153,684
600 Added 33.33%
2,400 $576,000
Q1 2023

Apr 05, 2023
SELL
$239.75 - $277.0 $239,750 - $277,000
-1,000 Reduced 35.71%
1,800 $453,000
Q4 2022

Jan 11, 2023
BUY
$241.42 - $282.29 $48,284 - $56,458
200 Added 7.69%
2,800 $743,000
Q3 2022

Oct 19, 2022
BUY
$247.06 - $1507.4 $17,294 - $105,518
70 Added 2.77%
2,600 $672,000
Q2 2022

Jul 08, 2022
BUY
$237.11 - $299.66 $599,888 - $758,139
2,530 New
2,530 $641,000
Q1 2022

Apr 21, 2022
SELL
$257.27 - $315.76 $162,080 - $198,928
-630 Closed
0 $0
Q4 2021

Jan 07, 2022
SELL
$292.08 - $329.01 $454,768 - $512,268
-1,557 Reduced 71.19%
630 $207,000
Q3 2021

Oct 08, 2021
SELL
$272.21 - $332.43 $77,579 - $94,742
-285 Reduced 11.53%
2,187 $666,000
Q1 2021

Apr 20, 2021
BUY
$212.38 - $245.9 $84,952 - $98,360
400 Added 19.31%
2,472 $556,000
Q4 2020

Jan 14, 2021
BUY
$212.5 - $245.46 $440,300 - $508,593
2,072 New
2,072 $460,000
Q3 2019

Oct 01, 2019
SELL
$135.4 - $146.47 $5.76 Million - $6.23 Million
-42,505 Closed
0 $0
Q2 2019

Jul 16, 2019
SELL
$124.88 - $143.73 $949,088 - $1.09 Million
-7,600 Reduced 15.17%
42,505 $6.08 Million
Q1 2019

Apr 30, 2019
BUY
$97.62 - $132.29 $521,778 - $707,090
5,345 Added 11.94%
50,105 $6.62 Million
Q4 2018

Jan 11, 2019
BUY
$94.85 - $109.54 $381,297 - $440,350
4,020 Added 9.87%
44,760 $4.62 Million
Q3 2018

Oct 19, 2018
SELL
$98.13 - $108.9 $314,016 - $348,480
-3,200 Reduced 7.28%
40,740 $4.43 Million
Q2 2018

Jul 09, 2018
BUY
$96.1 - $103.24 $166,733 - $179,121
1,735 Added 4.11%
43,940 $4.34 Million
Q1 2018

Apr 27, 2018
BUY
$92.16 - $103.8 $281,088 - $316,590
3,050 Added 7.79%
42,205 $4.13 Million
Q4 2017

Jan 17, 2018
SELL
$85.26 - $94.62 $170,520 - $189,240
-2,000 Reduced 4.86%
39,155 $3.63 Million
Q3 2017

Oct 16, 2017
BUY
$79.29 - $88.45 $3.26 Million - $3.64 Million
41,155
41,155 $3.53 Million

Others Institutions Holding DHR

# of Institutions
2,488
Shares Held
569M
Call Options Held
4.79M
Put Options Held
3.23M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $157B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email